secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sight Sciences, Inc. (SGHT)
CIK:        0001531177
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-163895
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 7.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sight Sciences reaffirms $89-94M 2023 revenue guidance; Palmetto proposes LCD deeming OMNI investigational
--------------------------------------------------------------------------------

- Reaffirmed FY 2023 revenue guidance of $89-94M (25-32% YoY growth) and average quarterly adjusted opex of ~$30.5M.
- Palmetto GBA published proposed LCD on June 8 classifying non-implantable MIGS (including OMNI) as investigational; open meeting July 17.
- Palmetto and WPS (proposed LCD June 1) states accounted for ~23% of 2022 Surgical Glaucoma revenue.
- NGS plans to publish proposed LCD on June 22 with open meeting July 13; five MACs covering 63% of revenue have discussed.
- Company says even if LCDs are finalized, no material impact on 2023 revenue due to 180-day implementation period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531177/000119312523163895/0001193125-23-163895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531177/000119312523163895/d449969d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-163895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer